These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 33999797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z, Pang Y, Wang Y, Cohen C, Zhao Y, Liu C.
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC, Wu MF, Chen HC, Huang WC.
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 8. Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility.
    Chang CL, Chen LC, Yu CJ, Hsueh PR, Chien JY.
    Int J Infect Dis; 2020 Sep; 98():33-40. PubMed ID: 32534139
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM, Alcaide F, Hyyryläinen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schön T, EUCAST AMST and ESCMYC study groups.
    Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
    [Abstract] [Full Text] [Related]

  • 12. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K.
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
    Zhao X, Wang Y, Pang Y.
    Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G, Wu L, Zheng Q, Jiang X.
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [Abstract] [Full Text] [Related]

  • 15. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan.
    Uwamino Y, Aoki W, Inose R, Kamoshita Y, Mikita K, Namkoong H, Nishimura T, Matsushita H, Hasegawa N.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0021824. PubMed ID: 38687080
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of bedaquiline against Mycobacterium avium complex.
    Litvinov V, Makarova M, Kudlay D, Nikolenko N, Mikhailova J.
    J Med Microbiol; 2021 Oct 04; 70(10):. PubMed ID: 34668850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    Lin S, Hua W, Wang S, Zhang Y, Chen X, Liu H, Shao L, Chen J, Zhang W.
    BMC Microbiol; 2022 Jul 08; 22(1):175. PubMed ID: 35804298
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.